References
1. Peters RL, Allen KJ, Dharmage SC, et al. Natural history of peanut
allergy and predictors of resolution in the first 4 years of life: A
population-based assessment. J Allergy Clin Immunol 2015;135:1257–1266
e1-2.
2. Graham F, Caubet JC, Eigenmann PA. Can my child with IgE-mediated
peanut allergy introduce foods labeled with “may contain traces”?
Pediatr Allergy Immunol 2020;6:601-607.
3. Yanagida N, Okada Y, Sato S, Ebisawa M. New approach for food allergy
management using low-dose oral food challenges and low-dose oral
immunotherapies. Allergol Int. 2016;65:135-140.
4. Simons FER, Ardusso LRF, Bilò MB, et
al. World allergy organization guidelines for the assessment and
management of anaphylaxis. World Allergy Organ J 2011;4:13-37.
5. Ebisawa M, Ito K, Fujisawa T. Japanese guidelines for food allergy
2020. Allergol Int 2020;69:370-386.
6. Midun E, Radulovic S, Brough H, Caubet J.C Recent advances in the
management of nut allergy. World Allergy Organ J 2021;14:100491.
7. Arkwright PD, MacMahon J, Koplin J, et al. Severity and threshold of
peanut reactivity during hospital-based open oral food challenges: An
international multicenter survey. Pediatr Allergy Immunol
2018;29:754-761.
8. Reier-Nilsen T, Michelsen MM, Lødrup Carlsen KC, et al. Predicting
reactivity threshold in children with anaphylaxis to peanut. Clin Exp
Allergy 2018 Apr; 48:415-423.
9. Nagakura KI, Yanagida N, Sato S, et al. Low-dose oral immunotherapy
for children with anaphylactic peanut allergy in Japan. Pediatr Allergy
Immunol 2018;29:512-518.
10. Nagakura KI, Yanagida N, Miura Y, et al. Long-term follow-up of
fixed low-dose oral immunotherapy for children with wheat-induced
anaphylaxis. J Allergy Clin Immunol Pract 2021;7:1117-1119.e2.